| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2005;36:1567.)
© 2005 American Heart Association, Inc.
Research Reports |
From the Division of Cardiology (P.P.T., A.K., N.M.B., E.F., J.G.Z.), General Clinical Research Center (E.O.), the Department of Physiological Nursing (B.J.D.), the Department of Neurology (N.K., W.S., W.L.Y.), and the Department of Neurological Surgery (M.T.L.), University of California, San Francisco.
Correspondence to Jonathan Zaroff, MD, 505 Parnassus Avenue, Moffitt Suite 1177, San Francisco, CA 94117-0124. E-mail Zaroff{at}medicine.ucsf.edu
Background and Purpose Serum B-type natriuretic peptide (BNP) is elevated after subarachnoid hemorrhage (SAH), as well as in the setting of congestive heart failure and myocardial infarction. The aim of this study was to prospectively quantify the relationship between BNP levels and cardiac outcomes after SAH.
Methods Plasma was collected for BNP measurements as soon as possible after enrollment; a mean of 5±4 days after SAH symptom onset. On days 1, 3, and 6 after enrollment, troponin I (cTi) was measured and 2-dimensional echocardiography was performed. The following cardiac variables were collected and treated dichotomously: left ventricular ejection fraction (LVEF), regional wall motion abnormalities (RWMA), diastolic dysfunction, pulmonary edema, and cTi.
Results There were 57 subjects. The median BNP level was 141 pg/mL (range, 0.8 to 3330 pg/mL). Higher mean BNP levels were present in those with RWMA (550 versus 261 pg/mL; P=0.012), diastolic dysfunction (360 versus 44; P=0.011), pulmonary edema (719 versus 204; P=0.016), elevated cTi (662 versus 240; P=0.004), and LVEF <50% (644 versus 281; P=0.015).
Conclusion Early after SAH, elevated BNP levels are associated with myocardial necrosis, pulmonary edema, and both systolic and diastolic dysfunction of the left ventricle. These findings support the hypothesis that the heart releases BNP into the systemic circulation early after SAH.
Key Words: aneurysm echocardiography natriuretic peptides, atrial stroke sympathetic nervous system
Related Article:
Stroke 2005 36: 1570-1571.
This article has been cited by other articles:
![]() |
K. A. Bybee and A. Prasad Stress-Related Cardiomyopathy Syndromes Circulation, July 22, 2008; 118(4): 397 - 409. [Full Text] [PDF] |
||||
![]() |
M. Maeder, T. Fehr, H. Rickli, and P. Ammann Sepsis-Associated Myocardial Dysfunction: Diagnostic and Prognostic Impact of Cardiac Troponins and Natriuretic Peptides Chest, May 1, 2006; 129(5): 1349 - 1366. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schillinger Editorial Comment--Brain Natriuretic Peptide and Early Cardiac Dysfunction After Subarachnoid Hemorrhage Stroke, July 1, 2005; 36(7): 1570 - 1571. [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |